Vancouver, Canada

Aarthi Jayanthan

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Phoenix Molecular Designs, Phoenix Molecular Design. Active years: 2017-2020.

USPTO Granted Patents = 3 

% Patents Active = 100.0


 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Vancouver, CA (2017 - 2018)
  • Richmond, CA (2020)

Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Aarthi Jayanthan: Innovator in Pharmaceutical Chemistry

Introduction

Aarthi Jayanthan is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. With a total of 3 patents to her name, her work focuses on innovative solutions for treating diseases associated with ribosomal S6 kinase (RSK) activity.

Latest Patents

Aarthi's latest patents include groundbreaking research on carboxamide derivatives that serve as RSK inhibitors. One of her notable inventions describes carboxamide derivatives that are useful as inhibitors of p90 ribosomal S6 kinase (RSK). These compounds are designed to treat diseases or conditions associated with RSK activity, particularly cancer. Another patent details substituted tetrahydropyrido[3',2':4,5]pyrrolo[1,2-α]pyrazine-2-carboxamides, which also function as RSK inhibitors. These derivatives are characterized by specific structural formulas that enhance their efficacy in pharmaceutical applications.

Career Highlights

Throughout her career, Aarthi has worked with various organizations, including Phoenix Molecular Designs. Her expertise in pharmaceutical chemistry has allowed her to contribute to the development of innovative therapeutic solutions.

Collaborations

Aarthi has collaborated with notable professionals in her field, including Jaipal Reddy Nagireddy and Subhash Annedi. These partnerships have further enriched her research and development efforts.

Conclusion

Aarthi Jayanthan is a trailblazer in the realm of pharmaceutical innovations, with a focus on RSK inhibitors that hold promise for cancer treatment. Her contributions to the field are marked by her patents and collaborations, showcasing her commitment to advancing medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…